Annemieke van Zante, MD, PhD


Dr. Annemieke van Zante is a pathologist at UCSF Medical Center who performs and interprets the results of fine needle aspiration biopsies at the Fine Needle Aspiration Clinic. She has a particular interest in head and neck pathology and also reviews specimens and provides consultations for head and neck cancer.

In her research, she focuses on the biological functions of carbohydrate sulfation in the regulation of growth factor signaling in cancer. Van Zante earned a medical degree and doctorate in the medical scientist training program, and completed a residency in anatomic pathology at UCSF. She also completed fellowships in surgical pathology and cytopathology, which is the study of abnormalities within cells, at UCSF. Van Zante is certified by the American Board of Pathology in anatomic patholoy and cytopathology, and is a UCSF associate professor of clinical pathology.


Fine Needle Aspiration Biopsy Clinic
1600 Divisadero St., Suite 200
San Francisco, CA 94143
Phone: (415) 353-7043
Fax: (415) 353-7676

Hours: Monday to Friday
9:30 a.m. – 5 p.m.

Fine Needle Aspiration Biopsy Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 353-7043
Fax: (415) 353-7676

Hours: Monday to Friday
9:30 a.m. – 5 p.m.

Board Certification

Cytopathology, American Board of Pathology

Academic Title

Associate Professor

More about Annemieke van Zante


UCSF School of Medicine 2004


UCSF Medical Center 2006


UCSF Medical Center 2007
UCSF Medical Center 2008

Selected Research and Publications

  1. Can NT, Lingen MW, Mashek H, McElherne J, Briese R, Fitzpatrick C, van Zante A, Cipriani NA. Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. Head Neck Pathol. 2017 Jul 05.
  2. Krings G, Joseph NM, Bean GR, Solomon D, Onodera C, Talevich E, Yeh I, Grenert JP, Hosfield E, Crawford ED, Jordan RC, van Zante A, Zaloudek C, Shin SJ, Chen YY. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol. 2017 Aug; 30(8):1086-1099.
  3. Wang SJ, Asthana S, van Zante A, Heaton CM, Phuchareon J, Stein L, Higuchi S, Kishimoto T, Chiu CY, Olshen AB, McCormick F, Tetsu O. Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. Oral Oncol. 2017 Jun; 69:1-10.
  4. Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, Koch W, Richmon JD, Eisele DW, D'Souza G. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 2017 May 01; 123(9):1566-1575.
  5. D'Souza G, Westra WH, Wang SJ, van Zante A, Wentz A, Kluz N, Rettig E, Ryan WR, Ha PK, Kang H, Bishop J, Quon H, Kiess AP, Richmon JD, Eisele DW, Fakhry C. Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method. JAMA Oncol. 2016 Dec 08.
  6. Goldstone RN, Hasan SR, Drury S, Darragh TM, van Zante A, Goldstone SE. A trial of radiofrequency ablation for anal intraepithelial neoplasia. Int J Colorectal Dis. 2017 Mar; 32(3):357-365.
  7. van Zante A, Ljung BM. Fine-needle aspiration versus core needle biopsy: Reconsidering the evidence of superiority. Cancer. 2016 Dec; 124(12):853-856.
  8. Lui NS, Yang YW, van Zante A, Buchanan P, Jablons DM, Lemjabbar-Alaoui H. SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer. PLoS One. 2016; 11(2):e0148911.
  9. North JP, McCalmont TH, Fehr A, van Zante A, Stenman G, LeBoit PE. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma. Am J Surg Pathol. 2015 Oct; 39(10):1347-56.
  10. Durr ML, van Zante A, Pletcher SD. An unusual presentation of a lingual dermoid cyst. Ear Nose Throat J. 2015 Oct-Nov; 94(10-11):E29-31.
  11. Phuchareon J, Overdevest JB, McCormick F, Eisele DW, van Zante A, Tetsu O. Fatty Acid binding protein 7 is a molecular marker in adenoid cystic carcinoma of the salivary glands: implications for clinical significance. Transl Oncol. 2014 Dec; 7(6):780-7.
  12. Phuchareon J, van Zante A, Overdevest JB, McCormick F, Eisele DW, Tetsu O. c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands. Transl Oncol. 2014 Oct; 7(5):537-45.
  13. Glastonbury CM, van Zante A, Knott PD. Ossification of the vascular pedicle in microsurgical fibular free flap reconstruction of the head and neck. AJNR Am J Neuroradiol. 2014 Oct; 35(10):1965-9.
  14. Heaton CM, Durr ML, Tetsu O, van Zante A, Wang SJ. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope. 2014 Jul; 124(7):E267-73.
  15. Gouveia C, Can NT, Bostrom A, Grenert JP, van Zante A, Orloff LA. Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1164-70.
  16. Heaton CM, Chazen JL, van Zante A, Glastonbury CM, Kezirian EJ, Eisele DW. Pleomorphic adenoma of the major salivary glands: diagnostic utility of FNAB and MRI. Laryngoscope. 2013 Dec; 123(12):3056-60.
  17. Shah AA, LeGallo RD, van Zante A, Frierson HF, Mills SE, Berean KW, Mentrikoski MJ, Stelow EB. EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma. Am J Surg Pathol. 2013 Apr; 37(4):571-8.
  18. Durr ML, van Zante A, Li D, Kezirian EJ, Wang SJ. Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival. Otolaryngol Head Neck Surg. 2013 Jul; 149(1):89-96.
  19. Ciau N, Eisele DW, van Zante A. Epithelioid schwannoma of the facial nerve masquerading as pleomorphic adenoma: a case report. Diagn Cytopathol. 2014 Jan; 42(1):58-62.
  20. Lui NS, van Zante A, Rosen SD, Jablons DM, Lemjabbar-Alaoui H. SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study. BMJ Open. 2012; 2(6).

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.